Thursday, February 12, 2015 Daily Archives

TiGenix and Lonza Sign Agreement for the Manufacture of Stem Cell-Based Treatment of Complex Perianal Fistulas in Crohn’s Disease

Lonza, a global leader in biological and cell therapy manufacturing and TiGenix, an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from allogeneic expanded adipose-derived stem cells (eASCs) in inflammatory and autoimmune diseases, announced today an agreement for the supply of TiGenix’s eASC product, Cx601. Under the agreement, Lonza will manufacture material for the Phase 3 trial of Cx601 in the US at Lonza’s cell therapy production facility in Walkersville, Maryland (US). Cx601 is a locally-injected suspension of…

Poster Hall and Awards Set to Launch at INTERPHEX 2015

International Pharmaceutical Expo (INTERPHEX), the premier pharmaceutical and biopharmaceutical event dedicated to innovation, technology and knowledge, and sponsored by the Parenteral Drug Association (PDA), and BioProcess International, a monthly magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics, today announced the addition of a Poster Hall held during INTERPHEX 2015 taking place April 21-23, Javits Center, New York, New York. Posters will be available on the show floor on Tuesday and Wednesday, April 21-22 from 9:00am-5:00pm. A…

INFORS HT Celebrates its 50th Anniversary

“We have always been rather unconventional” Back in 1965, Alexander Hawrylenko opened the Hawrylenko Technik in a vacant Basel kiosk. Fifty years later the name of the biotechnology specialist still incorporates his initials. By now, INFORS HT has become one of the world’s most prestigious developers and manufacturers of shakers, bioreactors and software. However, in this anniversary year 2015 the Swiss-based company is not just celebrating its own achievements but above all giving something back to its staff and to…